Member Info for thetriplestar

Close up looks like they signing away their lolly bags

The Government is talking about 'National Prosperity' because they already have their 17% locked in. They win no matter who owns HE1. Lorna is silent because she is no longer the captain of a ship; she’s a manager in a data room, waiting for the highest bidder to walk in.. definitely not a CEO. lol at the pictures - CEO & CFO look lightweight and out if their depth. Their comfort zone is issuing more shares to pay their salaries.

This is actually the one thing I am very happy for - the signing of the State Participation Agreement today isn't just a PR milestone; it is a structural change that makes the "Blank Cheque" dilution strategy much, much harder to pull off. The Tanzanian government doesn't want to see their "Strategic Asset" diluted into a penny-stock oblivion. They want the project built and producing royalties. If Carver tries to go for a "September Raise" that looks like a cash-grab rather than a development-fund, he now has to answer to a sovereign state that holds a seat at the Songwe Helium Ltd table. The government is the only entity that can pull the license - which is a much bigger threat than a disgruntled retail shareholder.

Finally someone actually agrees with me thanks JP2000

The geology is "A+," but the management of the "commercialization" is a "D-." We aren't being valued on the gas; we are being valued on the Board's perceived incompetence to bring that gas to market without eating the shareholders alive.

Lorna has successfully found the gas, but she has failed to sell the vision to anyone other than retail investors through dilutive raises. Why she is a CEO is beyond me. She is a Geologist but not CEO material.

With the government now sitting on the board of Songwe Helium Ltd, they will want to see "High-Grade Extraction" (as their PR stated) happen fast. They want royalties. This pressure from the top is the only thing that can force a "Lifestyle Board" to stop playing "penny-share games" and start behaving like a Major.

When the government uses language like 'Tanzania Rising,' they are making it politically impossible for the project to fail. They want the revenue, the jobs, and the prestige. Could be good buying next week with signing ceremony completed today.

You don't sign extraction agreements for 480 km² unless you have high confidence in the reserve volume. This is the government essentially saying, "The gas isn't just in one hole; it’s under this entire province.“

What’s happening here is a masterful piece of sovereign theater. By using hashtags like #FromSongweToTheWorld and #TanzaniaRising, the government is effectively tying their national reputation to Helium One’s success. For a company with a 0.6p share price, being the face of a "National Milestone" is the ultimate leverage.

Amazing to see Tanzanian govt doing a much better job promoting our project than Lorna’s Board. I’m really pleased we getting some exposure finally.

The price isn't moving because the "Supply of Shares" is currently equal to the "Demand for the News." We are stuck in a Liquidity Trap. It will take a "Circuit Breaker" event—like a confirmed takeover bid or a massive investment from a major partner—to blow through that 0.6p ceiling and finally align the share price with the geopolitical reality.

You can almost guarantee that at a £16M market cap, the "sharks" are circling and making those 1p–2p phone calls. The fact that the Board hasn't announced them means they are staying true to the "North Star" and waiting for the slam dunk that actually reflects the $1.2B benchmark.

Hi Hammer1979, to have a try at your question re a Slam Dunk offer level >> while the Board's "North Star" is the full Phase 3 completion, fiduciary duty kicks in if an offer is high enough.

A £250m–£300m bid: At a £16m market cap, an offer in this range represents a 1,500%+ premium.

The Share Price: This would translate to roughly 3.5p–4.5p.

The Decision: It is very difficult for a Board to tell shareholders to wait another two years for a potential 14p if a guaranteed 4p is on the table today.

With the market cap sitting at a mere £16m, Solvonis is currently priced as a "rounding error" for Big Pharma. While a predator might be tempted to swoop in with a £80m–£100m offer (1.2p–1.5p) to secure a Phase 3 asset and a global patent library for pennies on the pound, I reckon the Board would show them the door.

Why? Because they know the math:

The Broker Signal: Singer already has a 1.7p target on the screen today.

The Benchmark: They are tracking the $1.2bn Otsuka deal for the end-game.

The Monopoly: With US patents granted through 2043, you don’t trade a 17-year monopoly for a quick "exit" at 1.5p.

We aren’t looking for a "small dunk" that only covers the R&D budget of a major player; we’re holding for the valuation that reflects the true disruption of the AUD and PTSD markets.

The Board specifically mentioned they’ve already had "positive discussions" with counterparties.

The Trigger: If the WuXi Part 2 results are exceptional, a suitor might realize that waiting for the IND submission in Q4 2026 will make the company too expensive.

The "Otsuka" Fear: Big Pharma companies often buy clinical-stage peers simply to prevent a competitor (like Otsuka or J&J) from owning the dominant treatment in the space.

The door is never truly locked. A "slam dunk" offer from a Big Pharma player—looking to secure a Phase 3 asset before the price quintuples—could land at any moment......

BobbyBagger, the Board has secured the government's stake and the legal framework. Now, with Clive Carver as Chairman, they have the 'Broker' they need to either dilute the shareholders one more time in September or sell a controlling stake in this 'Strategically Important' asset.

Lorna is staying to see the 'Closing' through. James Smith left because........?

By publicly thanking the Government of Tanzania, the Board is signaling to the world—and potential buyers—that the "Political Risk" is now zero.

The recent RNS makes it clear: the Board isn't looking to "offload" SVN-001 cheaply because they see the massive value in finishing Phase 3. However, in the world of biotech, "not for sale" often translates to "make us an offer we can't refuse."